02.09.2024 • Topics
Expert Statement: Alex Del Priore, Syngene
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company

Syngene International Ltd.Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road
560 099 Bangalore
India
most read

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma

Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0









